TRPML1: A novel therapeutic target to remediate endolysosomal pathology in Alzheimers disease

Barry Boland

doi:10.1002/alz.043397

TRPML1: A novel therapeutic target to remediate endolysosomal pathology in Alzheimers disease

Barry Boland

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Alzheimer's and Dementia
DOIs	https://doi.org/10.1002/alz.043397
Publication status	Published - 2020

Keywords

Neurodegeneration
Neuroscience
Endosome
Biology
Lysosome
Neuropathology
Transient receptor potential channel
Hippocampal formation
Cell biology
Pathology
Disease
Medicine
Receptor
Intracellular
Genetics
Biochemistry
Enzyme

Access to Document

10.1002/alz.043397

https://openalex.org/W3111549503Licence: CC BY-NC-ND

Cite this

@article{ea1d67629d8240c39065e41afc2ad265,

title = "TRPML1: A novel therapeutic target to remediate endolysosomal pathology in Alzheimers disease",

keywords = "Neurodegeneration, Neuroscience, Endosome, Biology, Lysosome, Neuropathology, Transient receptor potential channel, Hippocampal formation, Cell biology, Pathology, Disease, Medicine, Receptor, Intracellular, Genetics, Biochemistry, Enzyme",

author = "Barry Boland",

year = "2020",

doi = "10.1002/alz.043397",

language = "English",

journal = "Alzheimer's and Dementia",

issn = "1552-5260",

publisher = "John Wiley and Sons Inc",

}

TY - JOUR

T1 - TRPML1: A novel therapeutic target to remediate endolysosomal pathology in Alzheimers disease

AU - Boland, Barry

PY - 2020

Y1 - 2020

KW - Neurodegeneration

KW - Neuroscience

KW - Endosome

KW - Biology

KW - Lysosome

KW - Neuropathology

KW - Transient receptor potential channel

KW - Hippocampal formation

KW - Cell biology

KW - Pathology

KW - Disease

KW - Medicine

KW - Receptor

KW - Intracellular

KW - Genetics

KW - Biochemistry

KW - Enzyme

U2 - 10.1002/alz.043397

DO - 10.1002/alz.043397

M3 - Article

SN - 1552-5260

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

ER -